Histogen

HSTO57

Penny Stock

$0.21arrow_drop_down1.13%-$0.00

Penny Stock

HSTO57

$0.21

arrow_drop_down1.13%-$0.00

Penny Stock

Performance History

Key Stats
Open	$0.22
Prev. Close	$0.22
EPS	-2.81
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$939.78K
PE Ratio	-

	LOW	HIGH
Day Range	0.22	0.22
52 Week Range	0.05	0.93

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-2.81

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About Histogen (HSTO)

Histogen Inc. (HSTO) is a biotech company that specializes in developing innovative therapies to address unmet needs in the field of regenerative medicine. The company is focused on harnessing the power of human cells and proteins to stimulate the body's natural regenerative processes. Histogen's flagship product is a proprietary liquid formula called HST-001, which is designed to promote hair growth in individuals with androgenic alopecia, also known as male pattern baldness. The product is currently in clinical trials and has shown promising results. Histogen is also working on developing therapies for other indications, including skin rejuvenation and joint regeneration.

As of the latest available market data, Histogen Inc. has a market capitalization of approximately $100 million. The company's stock, traded under the ticker symbol HSTO, has had a mixed performance in the market. Over the past 52 weeks, the stock has traded in a range of $2.50 to $10.00 per share. The stock's day range can vary depending on market conditions, but it has typically shown moderate volatility. Trading volume for Histogen Inc. tends to be relatively low, reflecting the company's early stage of development and the limited number of shares outstanding. The stock is listed on the NASDAQ exchange.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Dr. Stephen J. Mento Ph.D.
Headquarters: San Diego
Employees: 7
Exchange: NASDAQ

Keep an eye on Histogen

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is Histogen's (HSTO) price per share?

The current price per share for Histogen (HSTO) is $0.22. The stock has seen a price change of -$0 recently, indicating a -1.14% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for Histogen (HSTO)?

For Histogen (HSTO), the 52-week high is $0.93, which is 327.59% from the current price. The 52-week low is $0.05, the current price is 335% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is Histogen (HSTO) a growth stock?

Histogen (HSTO) has shown an average price growth of 0.41% over the past three years. It has received a score of -3 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Histogen as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is Histogen (HSTO) stock price performance year to date (YTD)?

As of the latest data, Histogen (HSTO) has a year-to-date price change of -29.84%. Over the past month, the stock has experienced a price change of -1.14%. Over the last three months, the change has been -32.03%. Over the past six months, the figure is -34.09%.

help

Is Histogen (HSTO) a profitable company?

Histogen (HSTO) has a net income of -$12.38M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -70.5K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$12.06M. Furthermore, the EBITDA is -$11.92M.

help

What is the market capitalization of Histogen (HSTO)?

Histogen (HSTO) has a market capitalization of $939.79K. The average daily trading volume is 297, indicating the stock's liquidity and investor engagement.